Minegishi and coworkers recently reported a successful case of salvage surgery following maintenance treatment with an anti-PD-L1 antibody (durvalumab) following concurrent chemo-radiotherapy (cCRT) for initially unresectable locally advanced NSCLC [9]. Here, CD274 is linked to non-small cell lung carcinoma.